Additionally, Alcântara et al. [44] proposed BChE to be secondary marker for metabolic syndrome in obese individuals with CHE2 C5− phenotype, while Rustemeijer et al. [35] suggested that BChE activity correlated with serum triacylglycerol and could therefore serve as a marker for the rate of triacylglycerol synthesis. Here, BCHE is linked to metabolic syndrome.